Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics

Sponsor
Fayoum University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05727969
Collaborator
(none)
90
1
2
10.5
8.6

Study Details

Study Description

Brief Summary

This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement.

Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups.

Preoperative Assessment:

All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications.

Perioperative Management:

Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.

Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted.

Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway.

Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg).

During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed.

At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators.

The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU.

Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours.

Statistical analysis

  • Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05.

  • Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
The group's allocations will be only blinded to assessors, data collectors, and parents of children
Primary Purpose:
Prevention
Official Title:
Effect Of Dexmedetomidine Infusion On Surgical Pleth Index In Pediatrics Undergoing Hypospadias Repair; A Prospective Observational Study
Actual Study Start Date :
Jan 15, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control group

The control group, lactated ringer solution will be infused.

Drug: Lactated Ringer
Lactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
Other Names:
  • Solution
  • Procedure: Hypospadias
    Children who will undergone hypospadias surgery
    Other Names:
  • pediatric manuvere
  • Device: Surgical pleth index
    The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
    Other Names:
  • SPI
  • Experimental: Dexmedetomidine group

    In the dexmedetomidine group, dexmedetomidine will be infused.

    Drug: Dexmedetomidine
    Dexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
    Other Names:
  • Precedex
  • Procedure: Hypospadias
    Children who will undergone hypospadias surgery
    Other Names:
  • pediatric manuvere
  • Device: Surgical pleth index
    The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
    Other Names:
  • SPI
  • Outcome Measures

    Primary Outcome Measures

    1. Surgical pleth index number [1 minute at end of the operation after skin closure.]

      from 0 to 100, higher values indicate strong surgical stimulus

    Secondary Outcome Measures

    1. Surgical pleth index number [1 minute before induction of anesthesia.]

      from 0 to 100, higher values indicate strong surgical stimulus

    2. Surgical pleth index number [1 minute after insertion of endotracheal tube.]

      from 0 to 100, higher values indicate strong surgical stimulus

    3. Surgical pleth index number [1 minute after beginning of surgery with skin incision.]

      from 0 to 100, higher values indicate strong surgical stimulus

    4. Surgical pleth index number [5 minutes after recovery at post anesthesia care unit.]

      from 0 to 100, higher values indicate strong surgical stimulus

    5. Mean arterial blood pressure [5 minutes after recovery at post anesthesia care unit.]

      in mmHg

    6. Mean arterial blood pressure [1 minute before induction of anesthesia.]

      in mmHg

    7. Mean arterial blood pressure [1 minute after beginning of surgery with skin incision.]

      in mmHg

    8. Heart rate [1 minute after beginning of surgery with skin incision.]

      beat/minute

    9. Heart rate [1 minute before induction of anesthesia.]

      beat/minute

    10. Heart rate [5 minutes after recovery at post anesthesia care unit.]

      beat/minute

    11. Heart rate [1 minute at end of the operation after skin closure.]

      beat/minute

    12. Mean arterial blood pressure [1 minute at end of the operation after skin closure.]

      mmHg

    13. Need of vasoactive drugs [1minute after infusion until end of surgery]

      Yes or no

    14. FLACC pain score [5 minutes after recovery in postanesthesia care unit]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    15. FLACC pain score [2 hours after recovery in postanesthesia care unit]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    16. Ramsay sedation score [5 minutes after recovery in postanesthesia care unit]

      0:5 with 0:deeply sedation to 5:no sedation

    17. Ramsay sedation score [2 hours after recovery in postanesthesia care unit]

      0:5 with 0:deeply sedation to 5:no sedation

    18. FLACC pain score [4 hours after discharge from recovery]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    19. FLACC pain score [6 hours after discharge from recovery]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    20. FLACC pain score [12 hours after discharge from recovery]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    21. FLACC pain score [24 hours after discharge from recovery]

      F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children

    22. Surgical time [1 minute after skin]

      from when the surgeon of record starts the procedure until complete skin closure in minutes

    23. Anesthesia time [5 minutes after insertion of endotracheal tube]

      from the start of anesthesia to the end of an anesthesia service in minutes

    24. Total opioid consumption [24 hours after operation]

      in milligram

    25. Time of 1st analgesia dose [24 hours postoperatively]

      time when first analgesic drug is injected for pain (in hours)

    26. Total non-steroidal consumption [24 hours postoperatively]

      time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours)

    27. Extubation time [2 minutes after removal of endotracheal tube]

      time from the end of surgery to airway extubation (in minutes)

    Other Outcome Measures

    1. Age [1 hour preoperatively]

      in years

    2. American society of anesthesiology classification [1 hour preoperatively]

      Either I: normal healthy or II: mild systemic disease

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Year to 7 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 1-7years.

    • ASA physical status I-II.

    • Hypospadias surgery.

    Exclusion Criteria:
    • Children having a history of mental retardation.

    • Developmental delay.

    • Allergic to dexmedetomedine.

    • Neuraxial anesthesia.

    • Cardiovascular disease.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fayoum University hospital Madīnat al Fayyūm Faiyum Governorate Egypt 63514

    Sponsors and Collaborators

    • Fayoum University Hospital

    Investigators

    • Study Director: Safaa G Megahed, MD, Fayoum University
    • Study Director: Omar S Mahmoud, MD, Fayoum University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Mohamed Ahmed Hamed, Associate professor of anesthesia, Fayoum University Hospital
    ClinicalTrials.gov Identifier:
    NCT05727969
    Other Study ID Numbers:
    • M637
    First Posted:
    Feb 14, 2023
    Last Update Posted:
    Feb 14, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Mohamed Ahmed Hamed, Associate professor of anesthesia, Fayoum University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 14, 2023